Abstract
An estimated 9 to 22 % of the pediatric age group are affected by the extremely broad range of childhood neurological disorders, which includes autism and other pervasive developmental disorders (PDD). As with most all of the neurodevelopmental disorders, the PDD spectrum disorders demonstrate a tremendous degree of clinical, biochemical, and genetic heterogeneity. In the great majority of cases, the underlying molecular defects are not known and both diagnosis and appropriate treatment remain challenging. Gene expression profiling using DNA microarrays is a useful tool to characterize cellular samples from patients with childhood neurological disorders. There are two principal goals in the characterization of transcriptional changes in these disorders: 1) Accurate molecular diagnosis of disorders in the absence of clear clinical or biochemical diagnostic markers. Additionally, analysis of transcriptional patterns can be used to generate sub-classifications of individual disorders. 2) Identificat ion of cellular systems that are disrupted in the disorder. Changes in the expression of individual genes as well as functionally related groups of genes can delineate biochemical pathways that are perturbed in a disorder. Both of these goals are ultimately directed at the development of effective therapeutic strategies. This review describes recent advances in these areas, discussing issues relevant to the study of gene expression in pediatric neurodevelopmental disorders.
Keywords: Microarrays, Brain Disorders, pervasive devleopment disorder pdd, hyperactivity disorder adhd, obseeive-compulsive disorder ocd
Current Genomics
Title: The Use of Microarrays to Study Childhood Developmental Brain Disorders
Volume: 3 Issue: 1
Author(s): C. Colantuoni, A. Comi, A. E. Purcell and J. Pevsner
Affiliation:
Keywords: Microarrays, Brain Disorders, pervasive devleopment disorder pdd, hyperactivity disorder adhd, obseeive-compulsive disorder ocd
Abstract: An estimated 9 to 22 % of the pediatric age group are affected by the extremely broad range of childhood neurological disorders, which includes autism and other pervasive developmental disorders (PDD). As with most all of the neurodevelopmental disorders, the PDD spectrum disorders demonstrate a tremendous degree of clinical, biochemical, and genetic heterogeneity. In the great majority of cases, the underlying molecular defects are not known and both diagnosis and appropriate treatment remain challenging. Gene expression profiling using DNA microarrays is a useful tool to characterize cellular samples from patients with childhood neurological disorders. There are two principal goals in the characterization of transcriptional changes in these disorders: 1) Accurate molecular diagnosis of disorders in the absence of clear clinical or biochemical diagnostic markers. Additionally, analysis of transcriptional patterns can be used to generate sub-classifications of individual disorders. 2) Identificat ion of cellular systems that are disrupted in the disorder. Changes in the expression of individual genes as well as functionally related groups of genes can delineate biochemical pathways that are perturbed in a disorder. Both of these goals are ultimately directed at the development of effective therapeutic strategies. This review describes recent advances in these areas, discussing issues relevant to the study of gene expression in pediatric neurodevelopmental disorders.
Export Options
About this article
Cite this article as:
Colantuoni C., Comi A., Purcell E. A. and Pevsner J., The Use of Microarrays to Study Childhood Developmental Brain Disorders, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350660
DOI https://dx.doi.org/10.2174/1389202023350660 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitrosative Stress as a Mediator of Apoptosis: Implications for Cancer Therapy
Current Pharmaceutical Design P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
Current Topics in Medicinal Chemistry Diffusion-Weighted Imaging in Abdominal Oncology
Current Medical Imaging PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
Current Medicinal Chemistry Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy
Current Pharmacogenomics and Personalized Medicine Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions
Current Vascular Pharmacology Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Current Cancer Drug Targets Sentinel Node Imaging
Current Medical Imaging Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Microsatellite Instability (MSI) as Genomic Marker in Endometrial Cancer: Toward Scientific Evidences
Mini-Reviews in Medicinal Chemistry Bio-analytical Identification of Key Genes that Could Contribute to the Progression and Metastasis of Osteosarcoma
Current Bioinformatics Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Current Genomics Development of an Intracellular, DNA Methyltransferase-Specific, and Gene-Specific Assay for Studying Dynamic DNA Methylation
Current Pharmaceutical Design Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Current Medicinal Chemistry Dietary Approaches and Alternative Therapies for Polycystic Ovary Syndrome
Current Nutrition & Food Science The Delicate Balance between the Good and the Bad IL-1 Proinflammatory Effects in Endometriosis
Current Medicinal Chemistry Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators
Medicinal Chemistry Minimally Invasive Approach to Endometrial Cancer: Robotics and Laparoscopy
Current Women`s Health Reviews Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design